Informing Implementation of a Circadian-Focused Intervention for Postpartum Depression
Recruiting · NCT07766161 · Interventional (participants receive a specific treatment)
View the official record on ClinicalTrials.gov →Interventions studied
Light therapy
What this trial is about
The proposed study is an open-label trial of Re-Timer® wearable morning bright light therapy for postpartum depression. The study is focused on evaluating the feasibility, acceptability, and implementation context of morning Bright Light Treatment (mBLT) for postpartum depression.
Who can take part
Age range
18 Years and older
Sex
Female
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- ≤ 6 months postpartum
- EPDS score \>10
Exclusion criteria
- Current or past-year substance use disorder
- Lifetime history of bipolar disorder or psychotic disorder
- Active suicidal intent
- Retinal pathology or history of eye surgery
- Current use of photosensitizing medications
- Untreated sleep-disordered breathing, untreated restless legs syndrome, or narcolepsy
- Psychotherapy or psychotropic medications started/dose changed in past month (psychotherapy started and/or current medication at stable dose ≥ 4 weeks are permitted)
- Medical conditions contraindicated for mBLT (e.g., epilepsy/seizures)
Where it is running
1 location listed across 1 US state.
- University of Michigan - Ann Arbor, Michigan, United States